Showing results (1-10 of 378) with videos related to
Sort By:
Pageof 38
Current Diabetes Reports|October 11, 2020
What Makes Sodium-Glucose Co-Transporter-2 Inhibitors Stand out in Heart Failure?Muhammad Shahzeb Khan, Muthiah VaduganathanCardiac Failure Review|November 27, 2019
Sodium-Glucose Cotransporter-2 Inhibitors and Heart Failure Prevention in Type 2 DiabetesMuhammad Shahzeb Khan, Javed ButlerInternational Journal of Biological Macromolecules|August 6, 2025
Environmentally sustainable removal of methylene blue, Congo red, naphthalene, and phenanthrene using chitosan tea waste composite beadsMuhammad Shahzeb Khan, Anna Maria SchmidtKidney International Reports|May 11, 2026
The Role of Finerenone in Cardiorenal Protection and Urine Albumin-to-Creatinine Ratio ModulationAjay K Singh, Muhammad Shahzeb KhanJournal of the College of Physicians and Surgeons--Pakistan : JCPSP|January 22, 2015
Endovascular treatment of renal artery stenosesMuhammad Nawaz Lashari, Muhammad Shahzeb KhanBMC Nephrology|August 1, 2024
Kidney and cardiovascular-protective benefits of combination drug therapies in chronic kidney disease associated with type 2 diabetesMuhammad Shahzeb Khan, Janice P LeaCurrent Problems in Cardiology|September 2, 2022
Reporting and Definition of Kidney Death in Heart Failure Clinical TrialsMuhammad Shahzeb Khan, Izza Shahid, Javed ButlerJournal of Cachexia, Sarcopenia and Muscle|February 20, 2025
Weight Gain Among Cancer Patients Receiving Chemotherapy-Facts and NumbersMuhammad Shahzeb Khan, Javed Butler, Markus AnkerThe American Journal of Cardiology|November 22, 2019
Variation in Placebo Effect on Health-Related Quality of Life in Heart Failure (from the TOPCAT Trial)Muhammad Shahzeb Khan, Andreas P Kalogeropoulos, Javed ButlerAnnals of Internal Medicine|July 31, 2023
In adults with HF, opioids do not reduce refractory breathlessness (low-certainty evidence)Muhammad Shahzeb Khan, Harriette G C Van SpallPageof 38